Figure 3From: Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagusComparison of survival of all node positive patients undergoing surgery alone and NT + surgery. Median survival time was 12.0 and 19.1 months, respectively.Back to article page